Form 4 holding
Director, 10%+ Owner
Immune Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 12,168,880
- Estimated value
- Report date
- 25 Jul 2022
- Price
- Ownership
- By trust
Henry Louis Salomonsky - Director, 10%+ Owner at Biostax Corp.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer symbol
- IMUN
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
No buys or sells have been reported by Henry Louis Salomonsky since 02 Jun 2025
Reported holdings for Henry Louis Salomonsky in Biostax Corp.
Form 4 holding
Director, 10%+ Owner
Immune Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 20
- Estimated value
- Report date
- 25 Jul 2022
- Price
- Ownership
- Direct
Transaction history for Henry Louis Salomonsky in Biostax Corp.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.